Botulinum Toxin Type A
Clostridium botulinum neurotoxin type A that cleaves SNAP-25 to temporarily block neuromuscular acetylcholine release, reducing expression line formation for
Buy more, save more
Total Price
$230
For research & laboratory use only. Not for human consumption.
Half-Life
~3-4 months (functional; SNAP-25 resynthesis timeline)
Administration Route
Intramuscular injection (facial muscles)
Neuromuscular Block
Cleaves SNAP-25 to prevent acetylcholine release at neuromuscular junction
Dynamic Wrinkle Elimination
Gold standard for glabellar lines, crow's feet, forehead
3-6 Month Duration
Single treatment produces predictable, reversible effect
Effect Profile
Skin Tone
Collagen Density
Anti-Wrinkle
Wound Healing
Mechanism of Action
Scientific Research
Ann Neurol (1999)
Plast Reconstr Surg (2002)
Aesthetic Plast Surg (2008)
Product FAQs
Stacks Well With
SNAP-8
Octapeptide that competes with SNAP-25 in the SNARE complex to reduce acetylcholine vesicle release at neuromuscular junctions, reducing expression line depth
Matrixyl 3000 (Palmitoyl Tripeptide-1 & Hexapeptide-12)
The most extensively clinically tested anti-aging peptide complex. Matrikine fragments activate fibroblasts to produce collagen I, III, VI, and fibronectin for
Related Products
SNAP-8
Octapeptide that competes with SNAP-25 in the SNARE complex to reduce acetylcholine vesicle release at neuromuscular junctions, reducing expression line depth
Matrixyl 3000 (Palmitoyl Tripeptide-1 & Hexapeptide-12)
The most extensively clinically tested anti-aging peptide complex. Matrikine fragments activate fibroblasts to produce collagen I, III, VI, and fibronectin for
Melanotan I (Afamelanotide)
Selective MC1R agonist (Scenesse) approved in EU/US for erythropoietic protoporphyria. Produces sustained melanin-based photoprotection without the behavioural